Bioanalysis of target biomarker and PK/PD relevancy during the development of biotherapeutics.
about
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis.Life cycle management of critical ligand-binding reagents.Analytical assay platforms for soluble target engagement biomarkers: old favorites and emerging technologies.Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies.Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics.Immunoaffinity LC-MS/MS for quantitative determination of a free and total protein target as a target engagement biomarker.
P2860
Bioanalysis of target biomarker and PK/PD relevancy during the development of biotherapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bioanalysis of target biomarke ...... evelopment of biotherapeutics.
@en
type
label
Bioanalysis of target biomarke ...... evelopment of biotherapeutics.
@en
prefLabel
Bioanalysis of target biomarke ...... evelopment of biotherapeutics.
@en
P2860
P356
P1433
P1476
Bioanalysis of target biomarke ...... evelopment of biotherapeutics.
@en
P2093
Hossein Salimi-Moosavi
Jean W Lee
P2860
P304
P356
10.4155/BIO.12.220
P577
2012-10-01T00:00:00Z